Vozenin MC - Search Results

1

Hypofractionated FLASH-RT as an Effective Treatment against Glioblastoma that Reduces Neurocognitive Side Effects in Mice.

Montay-Gruel P, Acharya MM, Gonçalves Jorge P, Petit B, Petridis IG, Fuchs P, Leavitt R, Petersson K, Gondré M, Ollivier J, Moeckli R, Bochud F, Bailat C, Bourhis J, Germond JF, Limoli CL, Vozenin MC. Montay-Gruel P, et al. Among authors: vozenin mc. Clin Cancer Res. 2021 Feb 1;27(3):775-784. doi: 10.1158/1078-0432.CCR-20-0894. Epub 2020 Oct 15. Clin Cancer Res. 2021. PMID: 33060122 Free PMC article.

2

What have we learned from human papillomavirus-positive tumors? Trying to connect data about biomarkers among human papillomavirus-related squamous cell carcinomas.

Vozenin MC, Bourhis J, Deutsch E. Vozenin MC, et al. J Clin Oncol. 2010 Jul 10;28(20):e340-1; author reply e342. doi: 10.1200/JCO.2010.27.9927. Epub 2010 May 10. J Clin Oncol. 2010. PMID: 20458036 No abstract available.

3

Epac contributes to cardiac hypertrophy and amyloidosis induced by radiotherapy but not fibrosis.

Monceau V, Llach A, Azria D, Bridier A, Petit B, Mazevet M, Strup-Perrot C, To TH, Calmels L, Germaini MM, Gourgou S, Fenoglietto P, Bourgier C, Gomez AM, Escoubet B, Dörr W, Haagen J, Deutsch E, Morel E, Vozenin MC. Monceau V, et al. Among authors: vozenin mc. Radiother Oncol. 2014 Apr;111(1):63-71. doi: 10.1016/j.radonc.2014.01.025. Epub 2014 Apr 7. Radiother Oncol. 2014. PMID: 24721545

4

Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice.

Favaudon V, Caplier L, Monceau V, Pouzoulet F, Sayarath M, Fouillade C, Poupon MF, Brito I, Hupé P, Bourhis J, Hall J, Fontaine JJ, Vozenin MC. Favaudon V, et al. Among authors: vozenin mc. Sci Transl Med. 2014 Jul 16;6(245):245ra93. doi: 10.1126/scitranslmed.3008973. Sci Transl Med. 2014. PMID: 25031268

5

The radiosensitizing activity of the SMAC-mimetic, Debio 1143, is TNFα-mediated in head and neck squamous cell carcinoma.

Matzinger O, Viertl D, Tsoutsou P, Kadi L, Rigotti S, Zanna C, Wiedemann N, Vozenin MC, Vuagniaux G, Bourhis J. Matzinger O, et al. Among authors: vozenin mc. Radiother Oncol. 2015 Sep;116(3):495-503. doi: 10.1016/j.radonc.2015.05.017. Epub 2015 Jun 18. Radiother Oncol. 2015. PMID: 26096848

6

Antifibrotic, Antioxidant, and Immunomodulatory Effects of Mesenchymal Stem Cells in HOCl-Induced Systemic Sclerosis.

Maria AT, Toupet K, Bony C, Pirot N, Vozenin MC, Petit B, Roger P, Batteux F, Le Quellec A, Jorgensen C, Noël D, Guilpain P. Maria AT, et al. Among authors: vozenin mc. Arthritis Rheumatol. 2016 Apr;68(4):1013-25. doi: 10.1002/art.39477. Arthritis Rheumatol. 2016. PMID: 26474311

7

PrP(c) deficiency and dasatinib protect mouse intestines against radiation injury by inhibiting of c-Src.

Strup-Perrot C, Vozenin MC, Monceau V, Pouzoulet F, Petit B, Holler V, Perrot S, Desquibert L, Fouquet S, Souquere S, Pierron G, Rousset M, Thenet S, Cardot P, Benderitter M, Deutsch E, Aigueperse J. Strup-Perrot C, et al. Among authors: vozenin mc. Radiother Oncol. 2016 Jul;120(1):175-83. doi: 10.1016/j.radonc.2016.06.009. Epub 2016 Jul 9. Radiother Oncol. 2016. PMID: 27406443

8

High dose-per-pulse electron beam dosimetry: Usability and dose-rate independence of EBT3 Gafchromic films.

Jaccard M, Petersson K, Buchillier T, Germond JF, Durán MT, Vozenin MC, Bourhis J, Bochud FO, Bailat C. Jaccard M, et al. Among authors: vozenin mc. Med Phys. 2017 Feb;44(2):725-735. doi: 10.1002/mp.12066. Epub 2017 Feb 8. Med Phys. 2017. PMID: 28019660

9

High dose-per-pulse electron beam dosimetry - A model to correct for the ion recombination in the Advanced Markus ionization chamber.

Petersson K, Jaccard M, Germond JF, Buchillier T, Bochud F, Bourhis J, Vozenin MC, Bailat C. Petersson K, et al. Among authors: vozenin mc. Med Phys. 2017 Mar;44(3):1157-1167. doi: 10.1002/mp.12111. Epub 2017 Feb 28. Med Phys. 2017. PMID: 28094853

10

How could breast cancer molecular features contribute to locoregional treatment decision making?

Tsoutsou PG, Vozenin MC, Durham AD, Bourhis J. Tsoutsou PG, et al. Among authors: vozenin mc. Crit Rev Oncol Hematol. 2017 Feb;110:43-48. doi: 10.1016/j.critrevonc.2016.12.006. Epub 2016 Dec 8. Crit Rev Oncol Hematol. 2017. PMID: 28109404 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

122 results

Search Page